Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Elanco Animal Health Inc’s stock clocked out at $12.93, down -0.15% from its previous closing price of $12.95. In other words, the price has decreased by $-0.15 from its previous closing price. On the day, 4.75 million shares were traded. ELAN stock price reached its highest trading level at $13.19 during the session, while it also had its lowest trading level at $12.725.
Ratios:
To gain a deeper understanding of ELAN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.66. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 0.95 whereas as Long-Term Debt/Eq ratio is at 0.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on January 05, 2024, Upgraded its rating to Buy and sets its target price to $20 from $13 previously.
On December 19, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $17.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 15, 2023, while the target price for the stock was maintained at $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 08 ’24 when DOYLE WILLIAM F bought 15,000 shares for $16.30 per share. The transaction valued at 244,500 led to the insider holds 61,330 shares of the business.
Harrington Michael J bought 3,100 shares of ELAN for $50,494 on Mar 08 ’24. The Director now owns 77,594 shares after completing the transaction at $16.29 per share. On Mar 06 ’24, another insider, HOOVER R DAVID, who serves as the Director of the company, bought 20,000 shares for $16.14 each. As a result, the insider paid 322,808 and bolstered with 185,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 6388674048 and an Enterprise Value of 11938102272. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.44 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 2.703 whereas that against EBITDA is 12.269.
Stock Price History:
The Beta on a monthly basis for ELAN is 1.35, which has changed by 0.3858521 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, ELAN has reached a high of $16.88, while it has fallen to a 52-week low of $7.88. The 50-Day Moving Average of the stock is -17.33%, while the 200-Day Moving Average is calculated to be -0.50%.
Shares Statistics:
It appears that ELAN traded 4.13M shares on average per day over the past three months and 4953950 shares per day over the past ten days. A total of 492.85M shares are outstanding, with a floating share count of 488.17M. Insiders hold about 0.97% of the company’s shares, while institutions hold 98.35% stake in the company. Shares short for ELAN as of 1711584000 were 12466528 with a Short Ratio of 3.01, compared to 1709164800 on 13685244. Therefore, it implies a Short% of Shares Outstanding of 12466528 and a Short% of Float of 3.08.
